Corporate Member Spotlight: Claritas Rx

NASP is pleased to shine the Spotlight on Claritas Rx, a corporate member of the month.  

Claritas Rx empowers market access teams with AI-driven insights into patient experiences and treatment barriers. Focused on specialty and rare diseases, they help teams track brand performance with comprehensive metrics, driving continuous improvement and improved patient outcomes. Their connections with key players in the biopharmaceutical sector provide them with an understanding of the latest industry progress, especially in the field of rare and specialty diseases.

For contact information and to learn more about Claritas Rx, please click here.